[Cite as http://purl.org/au-research/grants/nhmrc/1135657]
A/Pr David Nisbet
Brief description Several diseases, including Parkinson’s disease (PD), result in dementia. Currently, pharmacological therapy is the only treatment for PD dementia, which only offers symptomatic relief with diminished efficacy. Therefore, there is a need to develop new strategies that prevent or slow the onset of dementia. This study will utilize nanoscaffolds that facilitate the controlled delivery of therapeutic proteins to prevent or slow the death of neurons associated with dementia in PD patients.
Funding Amount $AUD 673,767.49
Funding Scheme Targeted Calls
Boosting Dementia Research Leadership Fellowship